Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort Meeting Abstract

  

Authors:	Matulonis, U. A.; Wulf, G.; Barry, W.; Birrer, M.; Westin, S.; Spagnoletti, T.; Bell-McGuinn, K.; Obermayer, E.; Whalen, C.; Aghajanian, C.; Solit, D.; Mills, G.; Cantley, L.; Winer, E.
Abstract Title:	Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort
Meeting Title:	106th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	75
Issue:	15 Suppl.
Meeting Dates:	2015 Apr 18-22
Meeting Location:	Philadelphia, PA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2015-08-01
Language:	English
ACCESSION:	WOS:000371597100096
DOI:	10.1158/1538-7445.am2015-ct324
PROVIDER:	wos
Notes:	Meeting Abstract: CT324 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/93048